Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Unknown 4 Terminated 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1

Interventions

Cyclophosphamide 6 fludarabine phosphate 5 Peripheral Blood Stem Cell Transplantation 5 Filgrastim 4 Whole-Body Irradiation 3 Rituximab 3 Etoposide 3 Cytarabine 3 Carmustine 3 Therapeutics 2 Tacrolimus 2 Saline Solution 2 Radiotherapy 2 Polymerase Chain Reaction 2 Pentetic Acid 2 O(6)-benzylguanine 2 Methotrexate 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Fibroblast Growth Factor 7 2 Dexamethasone 2 Busulfan 2 sargramostim 1 romidepsin 1 plerixafor 1 pembrolizumab 1 merphos 1 fludarabine 1 ferric pyrophosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Hodgkin Disease × ABVD protocol × Clear all

NCT01652261 2021-02-15

H11

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡